| 摘要 |
<p>Methods and reagents for analyzing differential expression and/or abundance of distinct membrane-associated polypeptide samples, particularly integral membrane polypeptide samples are provided. Also provides are methods for screening pharmaceutical components that can affect expression or abundance of certain membrane-associated polypeptides; methods for identification of drug targets; and methods for diagnosis of certain disease states. Business methods for conducting a pharmaceutical business based on the result of using the above methods are also provided.</p> |
